UPB - Upstream Bio, Inc.
7.37
0.970 13.161%
Share volume: 303,708
Last Updated: 04-11-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.14%
PREVIOUS CLOSE
CHG
CHG%
$6.40
0.97
0.15%
View ratios
| Fiscal Date | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | |
| Report Date | 11-07-2024 | 03-12-2025 | |
| Total revenue | 607.000 K | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | |
| Gross profit | 607.000 K | 0.000 | |
| -100.00% | |||
| Operating expenses | 19.500 M | 0.000 | |
| Selling general and admin | 4.067 M | 0.000 | |
| Research and development | 15.433 M | 0.000 | |
| Total expenses | 19.500 M | 0.000 | |
| -100.00% | |||
| Operating income | -18.893 M | 0.000 | |
| Ebit | -18.896 M | 0.000 | |
| Pretax income | -15.992 M | 0.000 | |
| -100.00% | |||
| Income tax | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | |
| Net income | -15.992 M | 0.000 | |
| 100.00% |
